Insights Exchange – What Drives Confidence in Translational Decision Making?

• Which datasets provide the greatest confidence when progressing a candidate?
• How can teams determine whether a preclinical signal is meaningful enough to justify investment?
• What are the biggest barriers to translating promising biology into clinical success?
• Audience Q&A

Speakers:

Lenka Sadilkova

Director, Non-Clinical Projects Operations

Eli Lilly & Co.

Sara Colombetti

Senior Leader-Head of Translational Pharmacology

Roche

John Bridgeman

Chief Scientific Officer

Immunokey